3+ week, 2+ day ago  (592+ words) Healing has often been framed within structured clinical environments, guided by formal processes and diagnostic language. For Hannah Hayden, founder of Sapphire Counseling, healing is centered around being more human. Her methodology reflects a belief that healing is shaped through…...

9+ hour, 12+ min ago  (302+ words) Gastro Med Miami becomes elea's first U. S. laboratory partner, replacing fragmented pathology IT with a unified, AI-native operating system. MIAMI, FL, UNITED STATES, May 27, 2026 /EINPresswire. com/ " elea, developer of the AI-native Pathology Operating System elea Lab, today announced its collaboration with…...

1+ hour, 9+ min ago  (97+ words) (Gray News) " Former Attorney General Pam Bondi has been diagnosed with thyroid cancer and is receiving treatment. Bondi revealed to CNN that she received the diagnosis after she was fired from her position in April. Bondi said she is undergoing…...

23+ hour, 42+ min ago  (93+ words) A Single, Integrated Workflow Across Three Category Leaders Ginkgo Datapoints: Data Generation. All five Tier 1 assays (microsomal stability, cell permeability, kinetic solubility, CYP inhibition, and plasma protein binding) are executed end-to-end in Ginkgo's automated laboratory in Boston. Validated, standardized workflows…...

1+ day, 10+ hour ago  (191+ words) U. S. Representatives Joe Courtney (D-CT-02), Glenn "GT'Thompson (R-PA-15), Suzan Del Bene (D-WA-01), and Ron Estes (R-KS-04) introduced companion legislation in the House. "When facing health challenges, seniors and their families shouldnt be burdened by unexpected medical expenses, said Rep. Thompson. "Medicare…...

2+ week, 1+ day ago  (122+ words) Announced that the first patient has been dosed in the NEO-CYT study, a randomized, investigator-initiated neoadjuvant Phase 1b trial evaluating MDNA11, Medicenna's long-acting, "beta-enhanced. .. Stocks in play: Medicenna Therapeutics Corp. Announced that the first patient has been dosed in the NEO-CYT study,…...

2+ week, 1+ day ago  (159+ words) NEO-CYT marks the first evaluation of MDNA11 in earlier-stage cancers, as a potentially curative treatment; extends development beyond the heavily pretreated metastatic setting of the ongoing Phase 1/2 ABILITY-1 study" NEO-CYT is a Phase 1b randomized, multi-centre trial sponsored by Fondazione Melanoma Onlus…...

3+ week, 2+ day ago  (508+ words) Alpha-synuclein is a small presynaptic protein that, under normal conditions, exists largely in a disordered conformation and participates in synaptic vesicle trafficking and neurotransmitter release. View the latest institution rankings View the latest Country/territory rankings Alpha-Synuclein Interactions in Neurodegenerative…...

3+ week, 6+ day ago  (771+ words) TORONTO and HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (Medicenna" or the Company") (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing. .. Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026 TORONTO and HOUSTON, April 30, 2026 (GLOBE NEWSWIRE)…...

6+ hour, 31+ min ago  (655+ words) Scientists at Northwestern University and University of California, Santa Barbara have created the first synthetic fragment of tau protein that acts like a prion. The "mini prion" folds and stacks into strands (or fibrils) of misfolded tau proteins, which then…...